Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated to version 2.14.1 on January 13, 2025, following the removal of version 2.14.0 on December 16, 2024.SummaryDifference1%
- Check13 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new addition was made on December 16, 2024, while there were deletions on November 13, 2024.SummaryDifference0.6%
- Check42 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check49 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has added new features for data download options, including formats like CSV, JSON, and FHIR, while removing several key government health-related links.SummaryDifference14%
Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.